Press Releases in Featured News

Alzheimer’s Drug Cuts Hallmark Inflammation Related to Metabolic Syndrome by 25 Percent


Feinstein Institute researchers repurpose existing medication with healing properties traced to ancient Greeks MANHASSET, NY – An existing Alzheimer’s medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the United States, according to new clinical trial results by scientists at… read more

posted in: Featured News tags: